글로벌 융모양막염 치료 시장 - 2028년까지의 산업 동향 및 예측

시장 분석 및 통찰력 : 글로벌 융모양막염 치료 시장

융모막염 치료 시장은 2021-2028년 예측 기간에 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 위에서 언급한 예측 기간에 시장이 5.30%의 CAGR로 성장할 것으로 분석합니다.

융모막염은 박테리아가 태반 과 자라나는 아기를 둘러싼 막(융모막과 양막)을 감염시키는 임신성 감염입니다 . 조산을 일으킬 수 있으며, 또한 어머니와 아기 사이의 영양소와 가스 교환을 방해할 수 있습니다. 이 박테리아 감염의 증상은 고열, 자궁 통증, 빠른 심박수, 변색되고 악취가 나는 양수입니다. 융모막염은 양막 내 감염 또는 자궁 내 감염이라고도 합니다.

융모막염의 유병률과 재발의 증가, 조기 진단에 대한 인식 제고, 의료비 지출 증가, 단백체 프로파일링과 같은 진단 절차의 급속한 증가, 정부 자금 지원 증가, 여성 건강에 대한 인식을 확산하기 위한 정부 및 민간 기관의 이니셔티브 증가는 융모막염 치료 시장을 확대할 요인입니다.

2021~2028년 예측 기간 동안 연구 개발 활동의 증가와 새로운 바이오마커의 식별은 융모양막염 치료 시장에 유익한 기회를 제공할 것입니다.

그러나 높은 치료 비용, 혈전, 자궁 내막염, 패혈증 및 골반 부위 감염과 같은 질병과 관련된 합병증, API에 대한 정부 규제의 급증은 시장 성장을 방해하는 요인이며, 위에서 언급한 예측 기간 동안 융모양막염 치료 시장에 더 큰 어려움을 초래할 것입니다.

This chorioamnionitis treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the chorioamnionitis treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Chorioamnionitis Treatment Market Scope and Market Size

The chorioamnionitis treatment market is segmented on the basis of treatment, diagnosis, dosage, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of treatment, the chorioamnionitis treatment market is segmented into antibiotics, surgery and others. Antibiotics have been further sub-segmented into metronidazole, ampicillin, gentamicin, penicillin and clindamycin,
• On the basis of diagnosis, the chorioamnionitis treatment market is segmented into blood tests, amniotic fluid testing, ultrasound and others.
• On the basis of dosage, the chorioamnionitis treatment market is segmented into tablet, injection and others.
• On the basis of route of administration, the chorioamnionitis treatment market is segmented into oral, intravenous and others.
• On the basis of end-users, the chorioamnionitis treatment market is segmented into clinic, hospital and others.

The chorioamnionitis treatment market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.

Chorioamnionitis Treatment Market Country Level Analysis

Chorioamnionitis treatment market is analyzed and market size information is provided by the country, treatment, diagnosis, dosage, route of administration, end-users and distribution channel as referenced above.

The countries covered in the chorioamnionitis treatment market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.

North America dominates the chorioamnionitis treatment market due to the presence of major key players, growing investment for R&D activities, high healthcare expenditure and well-developed healthcare infrastructure in this region. Asia-Pacific is expected to grow during the forecast period of 2021-2028 due to the increasing research and development activities, rising investment in the healthcare sector and growing number of cases of chorioamnionitis.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Chorioamnionitis treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Global Chorioamnionitis Treatment Market Share Analysis

Chorioamnionitis treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to global chorioamnionitis treatment market research.

융모양막염 치료 시장 보고서에 포함된 주요 기업으로는 Allergan, Zydus Cadila, Cipla Inc., Xellia Pharmaceuticals, Concord Biotech, Akums, Aristopharma Ltd., ACS Dobfar SpA, Sandoz International GmbH, Apotex Inc., Merck Sharp & Dohme Corp., Pfizer Inc., GlaxoSmithKline plc, Abbott, F. Hoffmann-La Roche Ltd., Mylan NV, Teva Pharmaceutical Industries Ltd., Sanofi, Novartis AG, Bayer AG, Sun Pharmaceutical Industries Ltd., Lilly, Aurobindo Pharma, Lupin, AbbVie Inc. 등이 있으며, 국내 및 글로벌 기업도 있습니다. 시장 점유율 데이터는 글로벌, 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA), 남미에 대해 각각 제공됩니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 개별적으로 제공합니다.

SKU-66454